2-201249901-T-C

Position:

• chr2-201249901-T-C

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The ENST00000264275.9(CASP8):​c.-27+15789T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.448 in 152,100 control chromosomes in the GnomAD database, including 17,553 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.45 (17553 hom., cov: 32)
• Consequence: CASP8 ENST00000264275.9 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.374

Genes affected

CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.6).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CASP8	NM_001080124.2	c.-27+15789T>C		intron_variant
CASP8	NM_001228.4	c.-27+15789T>C		intron_variant
CASP8	NM_001400648.1	c.-27+15789T>C		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
CASP8	ENST00000264275.9	c.-27+15789T>C		intron_variant		1
CASP8	ENST00000392258.7	c.-27+15789T>C		intron_variant		1
CASP8	ENST00000471383.5	n.250+15789T>C		intron_variant, non_coding_transcript_variant		1

Frequencies

GnomAD3 genomes AF: 0.448 AC: 68155 AN: 151982 Hom.: 17560 Cov.: 32

Gnomad AFR AF: 0.190

Gnomad AMI AF: 0.562

Gnomad AMR AF: 0.465

Gnomad ASJ AF: 0.440

Gnomad EAS AF: 0.472

Gnomad SAS AF: 0.340

Gnomad FIN AF: 0.560

Gnomad MID AF: 0.386

Gnomad NFE AF: 0.590

Gnomad OTH AF: 0.444

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.448 AC: 68142 AN: 152100 Hom.: 17553 Cov.: 32 AF XY: 0.443 AC XY: 32929 AN XY: 74336

Gnomad4 AFR AF: 0.189

Gnomad4 AMR AF: 0.465

Gnomad4 ASJ AF: 0.440

Gnomad4 EAS AF: 0.471

Gnomad4 SAS AF: 0.342

Gnomad4 FIN AF: 0.560

Gnomad4 NFE AF: 0.590

Gnomad4 OTH AF: 0.443

Alfa AF: 0.551 Hom.: 7498

Bravo AF: 0.433

Asia WGS AF: 0.391 AC: 1361 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.60
CADD	Benign	6.4
DANN	Benign	0.96

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs12990906; hg19: chr2-202114624;